Format

Send to

Choose Destination
Biochem Pharmacol. 2018 Jul;153:62-74. doi: 10.1016/j.bcp.2018.02.016. Epub 2018 Feb 15.

The G protein-coupled receptors deorphanization landscape.

Author information

1
Laboratory of Molecular Pharmacology, GIGA-Molecular Biology of Diseases, ULiège, Belgium.
2
Laboratory of Molecular Pharmacology, GIGA-Molecular Biology of Diseases, ULiège, Belgium; Laboratory of Medicinal Chemistry, CIRM-Drug target and Lead Discovery, ULiège, Belgium. Electronic address: j.hanson@uliege.be.

Abstract

G protein-coupled receptors (GPCRs) are usually highlighted as being both the largest family of membrane proteins and the most productive source of drug targets. However, most of the GPCRs are understudied and hence cannot be used immediately for innovative therapeutic strategies. Besides, there are still around 100 orphan receptors, with no described endogenous ligand and no clearly defined function. The race to discover new ligands for these elusive receptors seems to be less intense than before. Here, we present an update of the various strategies employed to assign a function to these receptors and to discover new ligands. We focus on the recent advances in the identification of endogenous ligands with a detailed description of newly deorphanized receptors. Replication being a key parameter in these endeavors, we also discuss the latest controversies about problematic ligand-receptor pairings. In this context, we propose several recommendations in order to strengthen the reporting of new ligand-receptor pairs.

KEYWORDS:

Deorphanization; Drug target; G protein-coupled receptor; Orphan GPCR

PMID:
29454621
DOI:
10.1016/j.bcp.2018.02.016

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center